Etest ECVs/ECOFFs for Detection of Resistance in Prevalent and Three Nonprevalent <i>Candida</i> spp. to Triazoles and Amphotericin B and Aspergillus spp. to Caspofungin: Further Assessment of Modal Variability

Ana Espinel‐Ingroff, Milène Sasso, John Turnidge, Maiken Cavling Arendrup, Françoise Botterel, Bernard Bouteille, Sophie Cassaing, Éric Dannaoui, Marion Déhais, Laurence Delhaès,

Antimicrobial Agents and Chemotherapy · 2021 · 17 citations · 23 references

DOIFull text

Open access

Concepts

Abstract

Susceptibility testing is an important tool in the clinical setting; its utility is based on the availability of categorical endpoints, breakpoints (BPs), or epidemiological cutoff values (ECVs/ECOFFs). CLSI and EUCAST have developed antifungal susceptibility testing, BPs, and ECVs for some fungal species.

References

23